Pfizer / Allergan

Pfizer Inc. said Nov. 23 that it will combine with Irish drugmaker Allergan plc in a tax-inversion deal valued at $160 billion. The transaction was the largest announced in 2015, which was the strongest year for M&A on record, according to data compiled by Thomson Reuters.